{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:09:14Z","timestamp":1792066154905,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Double Hundred Talents Support Program of Shanghai Jiaotong University School of Medicine"},{"name":"Shanghai Shuguang Plan Project","award":["18SG15"],"award-info":[{"award-number":["18SG15"]}]},{"name":"Shanghai outstanding young scholars Project"},{"name":"Clinical Research Plan of SHDC","award":["SHDC 2020CR2027B"],"award-info":[{"award-number":["SHDC 2020CR2027B"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31922029"],"award-info":[{"award-number":["31922029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61890951"],"award-info":[{"award-number":["61890951"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61890950"],"award-info":[{"award-number":["61890950"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai talent development project","award":["2019044"],"award-info":[{"award-number":["2019044"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anti-IgLON5 disease is a rare neurological disorder associated with autoantibodies against the neuronal cell adhesion protein, IgLON5. Cellular investigations with human IgLON5 antibodies have suggested an antibody-mediated pathogenesis, but whether human IgLON5 autoantibodies can induce disease symptoms in mice is yet to be shown. Moreover, the effects of anti-IgLON5 autoantibodies on neurons and the precise molecular mechanisms in vivo remain controversial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated the effects of anti-IgLON5 antibodies in vivo and evaluated their long-term effects. We used two independent passive-transfer animal models and evaluated the effects of the antibodies on mouse behaviors at different time points from day 1 until day 30 after IgG infusion. A wide range of behaviors, including tests of locomotion, coordination, memory, anxiety, depression and social interactions were established. At termination, brain tissue was analyzed for human IgG, neuronal markers, glial markers, synaptic markers and RNA sequencing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>These experiments showed that patient\u2019s anti-IgLON5 antibodies induced progressive and irreversible behavioral deficits in vivo. Notably, cognitive abnormality was supported by impaired average gamma power in the CA1 during novel object recognition testing. Accompanying brain tissue studies showed progressive increase of brain-bound human antibodies in the hippocampus of anti-IgLON5 IgG-injected mice, which persisted 30\u00a0days after the injection of patient\u2019s antibodies was stopped. Microglial and astrocyte density was increased in the hippocampus of anti-IgLON5 IgG-injected mice at Day 30. Whole-cell voltage clamp recordings proved that anti-IgLON5 antibodies affected synaptic homeostasis. Further western blot investigation of synaptic proteins revealed a reduction of presynaptic (synaptophysin) and post-synaptic (PSD95 and NMDAR1) expression in anti-IgLON5 IgG-injected mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Overall, our findings indicated an irreversible effect of anti-IgLON5 antibodies and supported the pathogenicity of these antibodies in vivo\n                      <jats:italic>.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-022-02520-z","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T04:02:56Z","timestamp":1654920176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice"],"prefix":"10.1186","volume":"19","author":[{"given":"You","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingding","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zike","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dou","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7428-7153","authenticated-orcid":false,"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"key":"2520_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, Contreras A, Giometto B, Compta Y, Embid C, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13:575\u201386.","journal-title":"Lancet Neurol"},{"key":"2520_CR2","doi-asserted-by":"crossref","unstructured":"Gaig C, Iranzo A, Cajochen C, Vilaseca I, Embid C, Dalmau J, Graus F, Santamaria J. Characterization of the sleep disorder of anti-IgLON5 disease. Sleep. 2019; 42.","DOI":"10.1093\/sleep\/zsz133"},{"key":"2520_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","volume":"132","author":"E Gelpi","year":"2016","unstructured":"Gelpi E, Hoftberger R, Graus F, Ling H, Holton JL, Dawson T, Popovic M, Pretnar-Oblak J, Hogl B, Schmutzhard E, et al. Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol. 2016;132:531\u201343.","journal-title":"Acta Neuropathol"},{"key":"2520_CR4","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1212\/NXI.0000000000000651","volume":"7","author":"ME Erro","year":"2020","unstructured":"Erro ME, Sabater L, Martinez L, Herrera M, Ostolaza A, GarciadeGurtubay I, Tunon T, Graus F, Gelpi E. Anti-IGLON5 disease: a new case without neuropathologic evidence of brainstem tauopathy. Neurol Neuroimmunol Neuroinflamm. 2020;7:e651.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2520_CR5","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.1212\/NXI.0000000000000605","volume":"6","author":"C Gaig","year":"2019","unstructured":"Gaig C, Ercilla G, Daura X, Ezquerra M, Fernandez-Santiago R, Palou E, Sabater L, Hoftberger R, Heidbreder A, Hogl B, et al. HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease. Neurol Neuroimmunol Neuroinflamm. 2019;6:e605.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2520_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","volume":"13","author":"L Sabater","year":"2016","unstructured":"Sabater L, Planaguma J, Dalmau J, Graus F. Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome. J Neuroinflammation. 2016;13:226.","journal-title":"J Neuroinflammation"},{"key":"2520_CR7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/ana.25857","volume":"88","author":"J Landa","year":"2020","unstructured":"Landa J, Gaig C, Plaguma J, Saiz A, Antonell A, Sanchez-Valle R, Dalmau J, Graus F, Sabater L. Effects of IgLON5 antibodies on neuronal cytoskeleton: a link between autoimmunity and neurodegeneration. Ann Neurol. 2020;88:1023\u20137.","journal-title":"Ann Neurol"},{"key":"2520_CR8","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41577-021-00543-w","volume":"21","author":"H Pruss","year":"2021","unstructured":"Pruss H. Autoantibodies in neurological disease. Nat Rev Immunol. 2021;21:798.","journal-title":"Nat Rev Immunol"},{"key":"2520_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/brain\/awu310","volume":"138","author":"J Planaguma","year":"2015","unstructured":"Planaguma J, Leypoldt F, Mannara F, Gutierrez-Cuesta J, Martin-Garcia E, Aguilar E, Titulaer MJ, Petit-Pedrol M, Jain A, Balice-Gordon R, et al. Human N-methyl d-aspartate receptor antibodies alter memory and behaviour in mice. Brain. 2015;138:94\u2013109.","journal-title":"Brain"},{"key":"2520_CR10","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1093\/brain\/awv257","volume":"138","author":"S Wright","year":"2015","unstructured":"Wright S, Hashemi K, Stasiak L, Bartram J, Lang B, Vincent A, Upton AL. Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model. Brain. 2015;138:3159\u201367.","journal-title":"Brain"},{"key":"2520_CR11","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1093\/brain\/awz119","volume":"142","author":"MP Giannoccaro","year":"2019","unstructured":"Giannoccaro MP, Menassa DA, Jacobson L, Coutinho E, Prota G, Lang B, Leite MI, Cerundolo V, Liguori R, Vincent A. Behaviour and neuropathology in mice injected with human contactin-associated protein 2 antibodies. Brain. 2019;142:2000\u201312.","journal-title":"Brain"},{"key":"2520_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108237","volume":"177","author":"J Li","year":"2020","unstructured":"Li J, Lu C, Gao Z, Feng Y, Luo H, Lu T, Sun X, Hu J, Luo Y. SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain. Neuropharmacology. 2020;177: 108237.","journal-title":"Neuropharmacology"},{"key":"2520_CR13","doi-asserted-by":"publisher","first-page":"102213","DOI":"10.1016\/j.isci.2021.102213","volume":"24","author":"Y Zeng","year":"2021","unstructured":"Zeng Y, Luo H, Gao Z, Zhu X, Shen Y, Li Y, Hu J, Yang J. Reduction of prefrontal purinergic signaling is necessary for the analgesic effect of morphine. iScience. 2021;24:102213.","journal-title":"iScience"},{"key":"2520_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41586-020-2235-7","volume":"581","author":"X Zhang","year":"2020","unstructured":"Zhang X, Lei B, Yuan Y, Zhang L, Hu L, Jin S, Kang B, Liao X, Sun W, Xu F, et al. Brain control of humoral immune responses amenable to behavioural modulation. Nature. 2020;581:204\u20138.","journal-title":"Nature"},{"issue":"1243\u20131251","key":"2520_CR15","volume":"29","author":"Y Yuan","year":"2019","unstructured":"Yuan Y, Wu W, Chen M, Cai F, Fan C, Shen W, Sun W, Hu J. Reward inhibits paraventricular CRH neurons to relieve stress. Curr Biol. 2019;29(1243\u20131251): e1244.","journal-title":"Curr Biol"},{"key":"2520_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12974-018-1141-5","volume":"15","author":"Y Liu","year":"2018","unstructured":"Liu Y, Zhang Y, Zheng X, Fang T, Yang X, Luo X, Guo A, Newell KA, Huang XF, Yu Y. Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice. J Neuroinflam. 2018;15:112.","journal-title":"J Neuroinflam"},{"issue":"347\u2013362","key":"2520_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2020.10.023","volume":"109","author":"X Huang","year":"2021","unstructured":"Huang X, Huang P, Huang L, Hu Z, Liu X, Shen J, Xi Y, Yang Y, Fu Y, Tao Q, et al. A visual circuit related to the nucleus reuniens for the spatial-memory-promoting effects of light treatment. Neuron. 2021;109(347\u2013362): e347.","journal-title":"Neuron"},{"key":"2520_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105636","volume":"169","author":"A Taleb","year":"2021","unstructured":"Taleb A, Zhou YP, Meng LT, Zhu MY, Zhang Q, Naveed M, Li LD, Wang P, Zhou QG, Meng F, Han F. New application of an old drug proparacaine in treating epilepsy via liposomal hydrogel formulation. Pharmacol Res. 2021;169: 105636.","journal-title":"Pharmacol Res"},{"key":"2520_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41582-020-0381-z","volume":"16","author":"B Sun","year":"2020","unstructured":"Sun B, Ramberger M, O\u2019Connor KC, Bashford-Rogers RJM, Irani SR. The B cell immunobiology that underlies CNS autoantibody-mediated diseases. Nat Rev Neurol. 2020;16:481\u201392.","journal-title":"Nat Rev Neurol"},{"key":"2520_CR20","first-page":"267","volume":"9","author":"Y Ni","year":"2021","unstructured":"Ni Y, Shen D, Zhang Y, Song Y, Gao Y, Zhou Q, He L, Yin D, Wang Y, Song F, et al. Expanding the clinical spectrum of anti-IgLON5 disease: a multicenter retrospective study. Eur J Neurol. 2021;9:267.","journal-title":"Eur J Neurol"},{"key":"2520_CR21","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000605","volume":"6","author":"C Gaig","year":"2019","unstructured":"Gaig C, Ercilla G, Daura X, Ezquerra M, Fernandez-Santiago R, Palou E, Sabater L, Hoftberger R, Heidbreder A, Hogl B, et al. HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease. Neurol Neuroimmunol Neuroinflamm. 2019;6: e605.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2520_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.expneurol.2012.10.013","volume":"239","author":"N Hansen","year":"2013","unstructured":"Hansen N, Grunewald B, Weishaupt A, Colaco MN, Toyka KV, Sommer C, Geis C. Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats. Exp Neurol. 2013;239:202\u20139.","journal-title":"Exp Neurol"},{"key":"2520_CR23","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1093\/brain\/awq253","volume":"133","author":"C Geis","year":"2010","unstructured":"Geis C, Weishaupt A, Hallermann S, Grunewald B, Wessig C, Wultsch T, Reif A, Byts N, Beck M, Jablonka S, et al. Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain. 2010;133:3166\u201380.","journal-title":"Brain"},{"issue":"91\u2013105","key":"2520_CR24","volume":"100","author":"H Haselmann","year":"2018","unstructured":"Haselmann H, Mannara F, Werner C, Planaguma J, Miguez-Cabello F, Schmidl L, Grunewald B, Petit-Pedrol M, Kirmse K, Classen J, et al. Human autoantibodies against the AMPA receptor subunit GluA2 induce receptor reorganization and memory dysfunction. Neuron. 2018;100(91\u2013105): e109.","journal-title":"Neuron"},{"key":"2520_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fneur.2015.00136","volume":"6","author":"H Haselmann","year":"2015","unstructured":"Haselmann H, Ropke L, Werner C, Kunze A, Geis C. Interactions of human autoantibodies with hippocampal GABAergic synaptic transmission\u2014analyzing antibody-induced effects ex vivo. Front Neurol. 2015;6:136.","journal-title":"Front Neurol"},{"key":"2520_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature08573","volume":"462","author":"LL Colgin","year":"2009","unstructured":"Colgin LL, Denninger T, Fyhn M, Hafting T, Bonnevie T, Jensen O, Moser MB, Moser EI. Frequency of gamma oscillations routes flow of information in the hippocampus. Nature. 2009;462:353\u20137.","journal-title":"Nature"},{"key":"2520_CR27","doi-asserted-by":"publisher","first-page":"e962","DOI":"10.1212\/NXI.0000000000000962","volume":"8","author":"J Werner","year":"2021","unstructured":"Werner J, Jelcic I, Schwarz EI, Probst-Muller E, Nilsson J, Schwizer B, Bloch KE, Lutterotti A, Jung HH, Schreiner B. Anti-IgLON5 disease: a new bulbar-onset motor neuron mimic syndrome. Neurol Neuroimmunol Neuroinflamm. 2021;8:e962.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2520_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1001\/jamaneurol.2019.3638","volume":"77","author":"H Chen","year":"2020","unstructured":"Chen H, Wu J, Irani SR. Distinctive magnetic resonance imaging findings in IgLON5 antibody disease. JAMA Neurol. 2020;77:125\u20136.","journal-title":"JAMA Neurol"},{"key":"2520_CR29","doi-asserted-by":"publisher","first-page":"e915","DOI":"10.1212\/NXI.0000000000000915","volume":"8","author":"A Garcia-Serra","year":"2021","unstructured":"Garcia-Serra A, Radosevic M, Pupak A, Brito V, Rios J, Aguilar E, Maudes E, Arino H, Spatola M, Mannara F, et al. Placental transfer of NMDAR antibodies causes reversible alterations in mice. Neurol Neuroimmunol Neuroinflamm. 2021;8:e915.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2520_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/ana.25829","volume":"88","author":"M Carceles-Cordon","year":"2020","unstructured":"Carceles-Cordon M, Mannara F, Aguilar E, Castellanos A, Planaguma J, Dalmau J. NMDAR antibodies alter dopamine receptors and cause psychotic behavior in mice. Ann Neurol. 2020;88:603\u201313.","journal-title":"Ann Neurol"},{"key":"2520_CR31","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/cells10040837","volume":"10","author":"M Ryding","year":"2021","unstructured":"Ryding M, Gamre M, Nissen MS, Nilsson AC, Okarmus J, Poulsen AAE, Meyer M, Blaabjerg M. Neurodegeneration induced by anti-IgLON5 antibodies studied in induced pluripotent stem cell-derived human neurons. Cells. 2021;10:837.","journal-title":"Cells"},{"key":"2520_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ana.24293","volume":"77","author":"X Peng","year":"2015","unstructured":"Peng X, Hughes EG, Moscato EH, Parsons TD, Dalmau J, Balice-Gordon RJ. Cellular plasticity induced by anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies. Ann Neurol. 2015;77:381\u201398.","journal-title":"Ann Neurol"},{"key":"2520_CR33","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/ana.25552","volume":"86","author":"B Jurek","year":"2019","unstructured":"Jurek B, Chayka M, Kreye J, Lang K, Kraus L, Fidzinski P, Kornau HC, Dao LM, Wenke NK, Long M, et al. Human gestational N-methyl-d-aspartate receptor autoantibodies impair neonatal murine brain function. Ann Neurol. 2019;86:656\u201370.","journal-title":"Ann Neurol"},{"key":"2520_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577114","volume":"339","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Zhu X, Meng H, Zhang M, Chen S. Anti-dipeptidyl-peptidase-like protein 6 encephalitis, a rare cause of reversible rapid progressive dementia and insomnia. J Neuroimmunol. 2020;339: 577114.","journal-title":"J Neuroimmunol"},{"key":"2520_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2021.173103","volume":"202","author":"XQ Zhang","year":"2021","unstructured":"Zhang XQ, Xu L, Ling Y, Hu LB, Huang J, Shen HW. Diminished excitatory synaptic transmission correlates with impaired spatial working memory in neurodevelopmental rodent models of schizophrenia. Pharmacol Biochem Behav. 2021;202: 173103.","journal-title":"Pharmacol Biochem Behav"},{"key":"2520_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077796","volume":"8","author":"X Xu","year":"2013","unstructured":"Xu X, An L, Mi X, Zhang T. Impairment of cognitive function and synaptic plasticity associated with alteration of information flow in theta and gamma oscillations in melamine-treated rats. PLoS ONE. 2013;8: e77796.","journal-title":"PLoS ONE"},{"key":"2520_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3233\/JAD-2010-100948","volume":"22","author":"J Liu","year":"2010","unstructured":"Liu J, Chang L, Roselli F, Almeida OF, Gao X, Wang X, Yew DT, Wu Y. Amyloid-beta induces caspase-dependent loss of PSD-95 and synaptophysin through NMDA receptors. J Alzheimers Dis. 2010;22:541\u201356.","journal-title":"J Alzheimers Dis"},{"key":"2520_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.pnpbp.2017.11.016","volume":"82","author":"AA Coley","year":"2018","unstructured":"Coley AA, Gao WJ. PSD95: a synaptic protein implicated in schizophrenia or autism? Prog Neuropsychopharmacol Biol Psychiatry. 2018;82:187\u201394.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2520_CR39","doi-asserted-by":"publisher","first-page":"1255263","DOI":"10.1126\/science.1255263","volume":"345","author":"H Hu","year":"2014","unstructured":"Hu H, Gan J, Jonas P. Interneurons. Fast-spiking, parvalbumin(+) GABAergic interneurons: from cellular design to microcircuit function. Science. 2014;345:1255263.","journal-title":"Science"},{"key":"2520_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/hipo.22228","volume":"24","author":"JB Trimper","year":"2014","unstructured":"Trimper JB, Stefanescu RA, Manns JR. Recognition memory and theta-gamma interactions in the hippocampus. Hippocampus. 2014;24:341\u201353.","journal-title":"Hippocampus"},{"key":"2520_CR41","doi-asserted-by":"publisher","first-page":"14495","DOI":"10.1073\/pnas.0701826104","volume":"104","author":"SM Montgomery","year":"2007","unstructured":"Montgomery SM, Buzs\u00e1ki G. Gamma oscillations dynamically couple hippocampal CA3 and CA1 regions during memory task performance. Proc Natl Acad Sci USA. 2007;104:14495\u2013500.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2520_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bbi.2020.06.001","volume":"89","author":"MH Ji","year":"2020","unstructured":"Ji MH, Lei L, Gao DP, Tong JH, Wang Y, Yang JJ. Neural network disturbance in the medial prefrontal cortex might contribute to cognitive impairments induced by neuroinflammation. Brain Behav Immun. 2020;89:133\u201344.","journal-title":"Brain Behav Immun"},{"key":"2520_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104625","volume":"134","author":"MR Hudson","year":"2020","unstructured":"Hudson MR, Sokolenko E, O\u2019Brien TJ, Jones NC. NMDA receptors on parvalbumin-positive interneurons and pyramidal neurons both contribute to MK-801 induced gamma oscillatory disturbances: complex relationships with behaviour. Neurobiol Dis. 2020;134: 104625.","journal-title":"Neurobiol Dis"},{"key":"2520_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A","volume":"10","author":"AM Thierry","year":"2000","unstructured":"Thierry AM, Gioanni Y, D\u00e9g\u00e9n\u00e9tais E, Glowinski J. Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus. 2000;10:411\u20139.","journal-title":"Hippocampus"},{"issue":"2588\u20132601","key":"2520_CR45","volume":"30","author":"SD Benthem","year":"2020","unstructured":"Benthem SD, Skelin I, Moseley SC, Stimmell AC, Dixon JR, Melilli AS, Molina L, McNaughton BL, Wilber AA. Impaired hippocampal\u2013cortical interactions during sleep in a mouse model of Alzheimer\u2019s disease. Curr Biol. 2020;30(2588\u20132601): e2585.","journal-title":"Curr Biol"},{"issue":"256\u2013271","key":"2520_CR46","volume":"177","author":"AJ Martorell","year":"2019","unstructured":"Martorell AJ, Paulson AL, Suk HJ, Abdurrob F, Drummond GT, Guan W, Young JZ, Kim DN, Kritskiy O, Barker SJ, et al. Multi-sensory gamma stimulation ameliorates Alzheimer\u2019s-associated pathology and improves cognition. Cell. 2019;177(256\u2013271): e222.","journal-title":"Cell"},{"key":"2520_CR47","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Munch AE, Chung WS, Peterson TC, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"2520_CR48","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","volume":"36","author":"H Lian","year":"2016","unstructured":"Lian H, Litvinchuk A, Chiang AC, Aithmitti N, Jankowsky JL, Zheng H. Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer\u2019s disease. J Neurosci. 2016;36:577\u201389.","journal-title":"J Neurosci"},{"key":"2520_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-170189","volume":"59","author":"A Cagnin","year":"2017","unstructured":"Cagnin A, Mariotto S, Fiorini M, Gaule M, Bonetto N, Tagliapietra M, Buratti E, Zanusso G, Ferrari S, Monaco S. Microglial and neuronal TDP-43 pathology in anti-IgLON5-related tauopathy. J Alzheimers Dis. 2017;59:13\u201320.","journal-title":"J Alzheimers Dis"},{"key":"2520_CR50","doi-asserted-by":"crossref","unstructured":"Strippel C, Heidbreder A, Schulte-Mecklenbeck A, Korn L, Warnecke T, Melzer N, Wiendl H, Pawlowski M, Gross CC, Kovac S. Increased intrathecal B and plasma cells in patients with anti-IgLON5 disease: a case series. Neurol Neuroimmunol Neuroinflamm 2022; 9.","DOI":"10.1212\/NXI.0000000000001137"},{"key":"2520_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fnmol.2018.00008","volume":"11","author":"K Karis","year":"2018","unstructured":"Karis K, Eskla KL, Kaare M, Taht K, Tuusov J, Visnapuu T, Innos J, Jayaram M, Timmusk T, Weickert CS, et al. Altered expression profile of IgLON family of neural cell adhesion molecules in the dorsolateral prefrontal cortex of schizophrenic patients. Front Mol Neurosci. 2018;11:8.","journal-title":"Front Mol Neurosci"},{"key":"2520_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.687536","volume":"15","author":"D Yin","year":"2021","unstructured":"Yin D, Chen S, Liu J. Sleep disturbances in autoimmune neurologic diseases: manifestation and pathophysiology. Front Neurosci. 2021;15: 687536.","journal-title":"Front Neurosci"},{"key":"2520_CR53","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1093\/brain\/awaa195","volume":"143","author":"F Mannara","year":"2020","unstructured":"Mannara F, Radosevic M, Planaguma J, Soto D, Aguilar E, Garcia-Serra A, Maudes E, Pedreno M, Paul S, Doherty J, et al. Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis. Brain. 2020;143:2709\u201320.","journal-title":"Brain"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02520-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-022-02520-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02520-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:05:55Z","timestamp":1654923955000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-022-02520-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2520"],"URL":"https:\/\/doi.org\/10.1186\/s12974-022-02520-z","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]},"assertion":[{"value":"12 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All in vivo and in vitro experiments were performed exactly as approved by the IACUC at Shanghai Jiaotong University and ShanghaiTech University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}